Literature DB >> 16172224

Racial differences in premenopausal endogenous hormones.

Simone P Pinheiro1, Michelle D Holmes, Michael N Pollak, Robert L Barbieri, Susan E Hankinson.   

Abstract

Differences in breast cancer incidence across racial groups are well documented. African Americans have the highest rates of premenopausal breast cancer and Asians have lower breast cancer rates across all age groups. We hypothesized that levels of premenopausal endogenous hormones and growth factors, risk factors that have been predictive of breast cancer, would differ by race. Using a cross-sectional study design, we tested this hypothesis in the Nurses' Health Study II. We assayed estradiol, progesterone, prolactin, sex hormone binding globulin (SHBG), insulin-like growth factor-I (IGF-I), and IGFBP-3 in 111 African American and 111 Asian American women, matched to 111 Caucasian women on age, day of luteal phase, and day, time, and fasting status at blood collection. We analyzed the association between race and hormone levels using robust linear regression methods. In multivariate models, compared with Caucasians, African Americans had 18% higher levels of estradiol (P < 0.01), 17% higher free estradiol (P < 0.01), 11% lower SHBG (P = 0.05), 11% higher IGF-I (P < 0.01), 25% higher free IGF-I (P < 0.01), and 9% lower IGFBP-3 (P < 0.01) levels. In multivariate models, compared with Caucasian women, Asian Americans had 22% higher calculated free estradiol (P < 0.01), 31% lower SHBG (P < 0.01), and 25% higher free IGF-I (P < 0.01) levels. No racial differences were found in progesterone and prolactin levels. Our study showed hormone differences consistent with breast cancer risk between Caucasians and African Americans but inconsistent with breast cancer risk between Asian Americans and Caucasians. Further research is needed to explore differences across racial groups and the link between endogenous hormones and breast cancer risk.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172224     DOI: 10.1158/1055-9965.EPI-04-0944

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  50 in total

1.  Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women.

Authors:  S Kalla Singh; Q W Tan; C Brito; M De León; D De León
Journal:  Growth Horm IGF Res       Date:  2010-03-27       Impact factor: 2.372

2.  Differences in ovarian hormones in relation to parity and time since last birth.

Authors:  Emily S Barrett; Lauren E Parlett; Gayle C Windham; Shanna H Swan
Journal:  Fertil Steril       Date:  2014-03-28       Impact factor: 7.329

3.  Breast cancer subtypes in Asian-Americans differ according to Asian ethnic group.

Authors:  Ellen Chuang; Christos Paul; Arielle Flam; Katherine McCarville; Melissa Forst; Sandra Shin; Linda Vahdat; Alexander Swistel; Rache Simmons; Michael Osborne
Journal:  J Immigr Minor Health       Date:  2012-10

Review 4.  COVID-19 in Africa: an ovarian victory?

Authors:  Osman A Dufailu; Afrakoma Afriyie-Asante; Bernard Gyan; David Adu Kwabena; Helena Yeboah; Frank Ntiakoh; Meshach Asare-Werehene
Journal:  J Ovarian Res       Date:  2021-05-21       Impact factor: 4.234

5.  Evidence that increased ovarian aromatase activity and expression account for higher estradiol levels in African American compared with Caucasian women.

Authors:  N D Shaw; S S Srouji; C K Welt; K H Cox; J H Fox; J M Adams; P M Sluss; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2013-11-27       Impact factor: 5.958

6.  Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women.

Authors:  E E Marsh; N D Shaw; K M Klingman; T O Tiamfook-Morgan; M A Yialamas; P M Sluss; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2011-08-17       Impact factor: 5.958

7.  Plasma IGF-1 and IGFBP-3 may be imprecise surrogates for breast concentrations: an analysis of healthy women.

Authors:  Adana A Llanos; Theodore M Brasky; Ramona G Dumitrescu; Catalin Marian; Kepher H Makambi; Bhaskar V S Kallakury; Scott L Spear; David J Perry; Rafael J Convit; Mary E Platek; Lucile L Adams-Campbell; Jo L Freudenheim; Peter G Shields
Journal:  Breast Cancer Res Treat       Date:  2013-03-02       Impact factor: 4.872

8.  Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES).

Authors:  Joellen M Schildkraut; Sarah E Abbott; Anthony J Alberg; Elisa V Bandera; Jill S Barnholtz-Sloan; Melissa L Bondy; Michele L Cote; Ellen Funkhouser; Lauren C Peres; Edward S Peters; Ann G Schwartz; Paul Terry; Sydnee Crankshaw; Fabian Camacho; Frances Wang; Patricia G Moorman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-12       Impact factor: 4.254

9.  Genetic Ancestry, Skin Reflectance and Pigmentation Genotypes in Association with Serum Vitamin D Metabolite Balance.

Authors:  Robin Taylor Wilson; Alanna N Roff; P Jenny Dai; Tracey Fortugno; Jonathan Douds; Gang Chen; Gary L Grove; Sheila Ongeri Nikiforova; Jill Barnholtz-Sloan; Tony Frudakis; Vernon M Chinchilli; Terryl J Hartman; Laurence M Demers; Mark D Shriver; Victor A Canfield; Keith C Cheng
Journal:  Horm Mol Biol Clin Investig       Date:  2011-09

10.  The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo.

Authors:  Jodie M Fleming; Tyler C Miller; Mariam Quinones; Zhen Xiao; Xia Xu; Matthew J Meyer; Erika Ginsburg; Timothy D Veenstra; Barbara K Vonderhaar
Journal:  BMC Med       Date:  2010-05-21       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.